Association of serum oncostatin M with disease severity and mortality in community-acquired pneumonia with diabetes mellitus

doi:10.4239/wjd.124628

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 11

This Article

(1)

(0)

(225)

Peer-Review Report of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Diabetes. Nov 15, 2026; 17(11): 124628
Published online Nov 15, 2026. doi: 10.4239/wjd.124628

Full Size Figure Download Figure

Figure 2 Serum oncostatin M levels among patients with diabetes mellitus-community-acquired pneumonia. A: Comparison between the severe community-acquired pneumonia and non-severe community-acquired pneumonia groups on admission; B: Paired comparison of serum oncostatin M levels on admission and on day 6. OSM: Oncostatin M; SCAP: Severe community-acquired pneumonia; NSCAP: Non-severe community-acquired pneumonia.

Citation: Sun Y, Li Q, Wang H, Gu MH, Teng PK, Zhang XY, Han XD, Liu XD. Association of serum oncostatin M with disease severity and mortality in community-acquired pneumonia with diabetes mellitus. World J Diabetes 2026; 17(11): 124628
URL: https://www.wjgnet.com/1948-9358/full/v17/i11/124628.htm
DOI: https://dx.doi.org/10.4239/wjd.124628

Sun Y, Li Q, Wang H, Gu MH, Teng PK, Zhang XY, Han XD, Liu XD. Association of serum oncostatin M with disease severity and mortality in community-acquired pneumonia with diabetes mellitus. World J Diabetes 2026; 17(11): 124628 [DOI: 10.4239/wjd.124628]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.